Moleculin Biotech, Inc. — Director's Dealing 2022

Mar 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2022-03-01

Reporting Person: Yan Joy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-01	Stock Option (right to buy)	$1.38	A	6667	Acquired	2032-03-01	Common Stock (6667)	Direct

Footnotes

F1: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

F2: The options were issued in connection with the reporting person's Board of Director service to the Company.